FH-001

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameFH-001
Drug Alias NameFH001FH-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathic painAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companies恒济医药（上海）有限公司
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active Companies恒济医药（上海）有限公司Haimen Pharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathic painAcute Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A